Our results showed that EBP50 can inhibit EGF-stimulated breast cancer cell proliferation and EGFR pathway activation, supporting a role for EBP50 in inhibiting EGF-induced cell proliferation by blocking EGFR phosphorylation in breast cancer cells. The gene discussed is EGFR; the disease is breast carcinoma.